Dutton Assoc Announces Investment Opinion: Neurobiological Technologies Strong Speculative Buy Rating Maintained in Updated Coverage by Dutton Assoc
13th Nov 2006, 20:17 GMT
Dutton Assoc updates its coverage of Neurobiological Technologies maintaining a Strong Speculative Buy rating and a 12-month target price of $8.
Dutton Assoc Announces Investment Opinion: Neurobiological Technologies Strong Speculative Buy Rating Maintained in Updated Coverage by Dutton Assoc related news:
- Neurobiological Technologies Review Issued by Scimitar Equity Research — Neurology News from StratCenter.com
- IO Circuit: (OTC: AXTG) Brought to You First by TheCapitalReport.com — Market Wire - Investment Opinion
- TheSUBWAY.com: Hot Stocks to Watch for Monday, November 13, 2006: Now Trading as Newly Reorganized Entity! — Market Wire - Investment Opinion
- MQ Assoc Announces Results for Q3 of 2006 and 9 Months Ended 9/30/2006 — Executive Announcements News from StratCenter.com
- Investment firms agree to buy Eddie Bauer — bizjournals.com Retailing & Restaurants:Retailing headlines
- Investment firms to buy retailer Eddie Bauer — bizjournals.com Retailing & Restaurants:Retailing headlines
- Intelligent Medical Objects and Bond Technologies Sign Multi-year Agreement — StratWire - Business of Healthcare NewsFeed
- MTM Technologies Announces Second Quarter Fiscal 2007 Results — Speech Technologies
- - Webcast Alert: Isis Pharmaceuticals Announces Its Analyst/Investor Webcast Presentation — Partnerships/ Joint Ventures News from StratCenter.com
- Good public services require investment — The Irish Times' Opinion Top Stories
Latest news from Financial News News from StratCenter.com:
- TRADE NEWS: Agilent Technologies Introduces High-Speed, High-Volume USB Multifunction Data Acquisition Modules, Chassis
- Bio-Rad Closes Buy of Ciphergen Unit
- The LGL Group Reports Q3 Earnings
- Analogic CEO to retire
- Analogic CEO Plans to Retire
- Meade Instruments Contracts with Leading Asian Outsource Manufacturing Firm
- JMAR Receives Nasdaq Delisting Notice
- Analogic Corp Announces Mgmt Changes
- Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems
- Agilent to buy Switzerland's Acqiris